Elucidating the mechanisms of action of parecoxib in the MG-63 osteosarcoma cell line-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Elucidating the mechanisms of action of parecoxib in the MG-63 osteosarcoma cell line

Published:2020-06 Issue:5 Volume:31 Page:507-517
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Lemos Sílvia,Sampaio-Marques Belém,Ludovico Paula,Gaivão Isabel,Palmeira Carlos,Martins Gabriela,Peixoto Francisco,Pinto-Leite Rosário,Oliveira Paula

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference50 articles.

1. Cancer and inflammation.;Munn;Wiley Interdiscip Rev Syst Biol Med,2017

2. Resolution of cancer-promoting inflammation: a new approach for anticancer therapy.;Zhang;Front Immunol,2017

3. Parecoxib inhibits glioblastoma cell proliferation, migration and invasion by upregulating mirna-29c.;Li;Biol Open,2017

4. Underlying causes and therapeutic targeting of the inflammatory tumor microenvironment.;Comen;Front Cell Dev Biol,2018

5. Use of parecoxib by continuous subcutaneous infusion for cancer pain in a hospice population.;Armstrong;BMJ Support Palliat Care,2018

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Parecoxib inhibits tumorigenesis and angiogenesis in hepatocellular carcinoma through ERK–VEGF/MMPs signaling pathway;IUBMB Life;2024-06-14

2. MRI apparent diffusion coefficient as potential biomarkers in the diagnosis of osteosarcoma;2023-11-21

3. Distinctions in bone matrix nanostructure, composition, and formation between osteoblast-like cells, MG-63, and human mesenchymal stem cells, UE7T-13;Heliyon;2023-05

4. The Relationship between PBLS and Osteosarcoma Distribution in Different Subgroups and the Survival and Prognosis of Osteosarcoma;Journal of Oncology;2023-04-07

5. RETRACTED ARTICLE:Parecoxib inhibits esophageal squamous cell carcinoma progression via the PDK1–AKT pathway;Cellular & Molecular Biology Letters;2022-03-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3